N-Power Medicine Revenue and Competitors
Employee Data
- N-Power Medicine has 88 Employees.
- N-Power Medicine grew their employee count by 38% last year.
N-Power Medicine's People
Name | Title | Email/Phone |
---|
N-Power Medicine Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is N-Power Medicine?
N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors.\n\nThe N-Power Platform consists of: \n- The real-time Kaleido™ Registry, conducted with patient consent, that defines \n standardized data collection at the point of care and is malleable to partner \n needs, \n- A technology solution that enables data collection and analysis, and\n- Embedded on-site and virtual staff who support delivery of routine care, \n implement standardized, registry protocol-defined data collection and augment \n site staff in clinical research. \n\nBy partnering with oncologists, research staff and patients in unlocking the full potential of every patient’s data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development.
keywords:N/AN/A
Total Funding
88
Number of Employees
N/A
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 89 | 13% | N/A |
#2 | $7.8M | 89 | 37% | N/A |
#3 | $24M | 89 | 7% | N/A |
#4 | $14M | 90 | -25% | $656.6M |
#5 | $18.5M | 90 | -6% | N/A |